Avacta completes fourth dose escalation in tumor study
Avacta Group plc says that AVA6000 continues to show a favorable safety profile in the…
January 19, 2023 - 3 minutes
Avacta Group plc says that AVA6000 continues to show a favorable safety profile in the…
AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) for patients…
Biotech company, Sensorion, today (October 24) announced that the initiation of a proof of concept…